IMMUNOVIA AB financial statements, including revenue, expenses, profit, and loss

The total revenue of IMMNOV for the last quarter is 85.00 k SEK, and it's 45.51% lower compared to the previous quarter. The net income of Q2 24 is -25.60 M SEK.